Home › Targets › KRAS
KRAS (4 companies · 11 programs)
Companies with an active program directed at KRAS.
- BBO-11818 — Non-Small Cell Lung Cancer Phase 1
- BBO-11818 — Colorectal Cancer Phase 1
- BBO-11818 — Pancreatic Ductal Adenocarcinoma Phase 1
- BBO-10203 — Colorectal Cancer Phase 1
- BBO-10203 — Non-Small Cell Lung Cancer Phase 1
- BBO-10203 — Pancreatic Ductal Adenocarcinoma Phase 1
- ELI-002 7P — Pancreatic Ductal Adenocarcinoma Phase 2
- ELI-002 2P — Pancreatic Ductal Adenocarcinoma Phase 1
- ELI-002 7P — Colorectal Cancer Phase 1
- pan-KRAS degrader Preclinical
- ERAS-4001 — Solid Tumors Phase 1
